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RESULTS

INTRODUCTION





PURPOSE
To assess the safety and efficacy of using low-dose ketamine (LDK) for
pain management. Data will be used to evaluate the use of ketamine in
treating mild-to-severe pain in a high-volume community hospital
emergency department, and to recommend a dosing guideline for its use
in the ED.

Average Dosing of LDK by Indication

Pain Rating on a Visual Analogue Scale
(0 = no pain; 10 = worse pain imaginable)



In the emergency department (ED) many barriers exist to pain
management, including its subjective nature, regulatory issues,
knowledge deficits, and fear concerning therapy.
NSAIDs and acetaminophen often cannot provide enough relief.
Opioids have significant adverse effect profiles and are hindered by
side effects, dependency, and tolerance.
o The Joint Commission highlighted issues with opioid prescribing
and related adverse events in a 2012 Sentinel Event Alert.
o The American College of Emergency Physicians has instituted
efforts to reduce unnecessary and improper opioid prescribing.
A non-competitive NMDA receptor antagonist with properties that
allow for little respiratory depression, ketamine has historically been
used for sedation and anesthesia in settings with limited resources.
Ketamine’s unique safety profile in the anesthetic setting and variety
of dosage forms indicate its potential role in pain management.
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Study Design: An observational study utilizing retrospective medical
chart reviews of a sample of patients who received low-dose ketamine
during a visit to the Emergency Department at Homestead Hospital.
Sample Size: 24 subjects.
Inclusion Criteria: Admission to the Homestead Hospital ED for
treatment of acute or chronic mild, moderate, or severe pain with
ketamine between June 2014 and June 2015.
Exclusion Criteria: Administration of ≥ 1 mg/kg of ketamine.
Instruments: The Wong-Baker FACES Pain Rating Scale for children, a
1-10 Visual Analogue Scale for adults, and provider documentation.
Procedures: A retroactive computerized report was generated to identify
all patients who received ketamine in the ED between June 2014 and
June 2015. Any patients who did not fit the study criteria were excluded.
Subjects’ profiles were then reviewed by a pre-specified investigator to
determine how LDK was used to treat patients’ pain symptoms. Safety
and effectiveness were assessed by the incidence of adverse events and
changes in subjectively reported pain-rating scores, respectfully.
Statistical Analysis: Descriptive statistics were generated using Microsoft
Office Excel 2007 to assess how LDK was used in the ED, for what
indications, the safety profile of the dosage range being used, and the
effectiveness of LDK in reducing pain.
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Age (yr), average
Weight (kg), average
Sex
Female (%)
Male (%)
Baseline Pain Score
Mild (%)
Moderate (%)
Severe (%)
Post-LDK Pain Score
None (%)
Mild (%)
Moderate (%)
Severe (%)

8
6
4
2
0

Ketamine
alone
7.3
1.8

Adjunctive to
Analgesics
8.5
2.5

Adjunctive to
Sedatives
7.6
2.3

DISCUSSION



METHODS
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Administration Routes
Continuous Intranasal 4%
(n=1)
Infusion 15%
(n=4)

Decreased SpO2
Vomiting 4%
4% (n=1)
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Change in Pain from Baseline

Patient Demographics (n=24)
34.4
Existing Precautions (%)
70.5
Coronary Artery Disease (%)
Heart Failure (%)
54
Hypertension (%)
46
Baseline Vital Signs
Heart Rate (bpm), average
4.3
Systolic Blood Pressure (mmHg), average
8.7
Diastolic Blood Pressure (mmHg), average
87
Oxygen Saturation (%), average
History of Chronic Pain (%)
42.9
History of Opioid Use (%)
28.6
Opioid use within the past 24 hours (%)
23.8
4.8

25
8.3
8.3
20.8
104
129
79
99
37.5
37.5
37.5

Of 113 subjects with orders for ketamine, 24 met inclusion criteria.
o 34 ketamine orders were discontinued prior to administration.
 1 patient refused treatment with LDK.
o 55 subjects received ≥ 1 mg/kg of ketamine.
A total average dose of 0.375 mg/kg was administered for eight
distinct indications, with the highest doses being used for laceration
repair and the lowest for a hairline fracture.
Ketamine monotherapy reduced an average baseline pain rating of
Severe to Mild upon discharge, in a manner similar to
coadministration with analgesics and sedative agents.
Common coadministered medications included opioid and nonopioid analgesics, ondansetron, and propofol.
Two adverse drug events were reported for separate subjects.
o Twenty minutes after ketamine administration, a patient
vomited yellow bile. Per patient request, ketamine drip was held.
Patient was nauseous upon presentation.
o Three minutes after ketamine administration, oxygen saturation
decreased 5% and then returned to baseline after five minutes.

CONCLUSIONS




Low-dose ketamine was safely administered to treat a variety of
different indications in opioid-naïve and opioid-tolerant patients.
Ketamine was effective in doses < 1 mg/kg for providing emergency
analgesia in the ED, both as monotherapy and adjunctively.
Disclosure: The authors of this presentation have nothing to disclose concerning
possible financial or personal relationships with commercial entities that may
have a direct or indirect interest in the subject matter of this presentation.

